Valuation: Kamada Ltd.

Market Cap 1.3B 0 435M 380M 349M 325M 617M 41.38B 627M 4.2B 1.63B 20.3B 1.63B 1.6B 69.94B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.3B 0 435M 380M 349M 325M 617M 41.38B 627M 4.2B 1.63B 20.3B 1.63B 1.6B 69.94B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 2.03x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day-0.31%
1 week+5.63%
Current month+2.93%
1 month+5.93%
3 months-13.19%
6 months-1.10%
Current year-0.44%
1 week 2,130
Extreme 2130
2,297
1 month 2,083
Extreme 2083
2,297
Current year 2,083
Extreme 2083
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 2015-06-30
Director of Finance/CFO 55 2017-12-30
Chief Operating Officer 53 2016-10-31
Director TitleAgeSince
Director/Board Member 75 1990-12-12
Chairman 77 2013-03-06
Chairman 55 2020-08-11
Date Insider Type Main position Quantity % Market Cap.
Apr. 06Free

Responsable ventes & marketing

150,000 0.2600%
Apr. 06Free

Head of Human Resources

200,000 0.3467%
Apr. 06Free

General Counsel

198,970 0.3449%
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%+5.63%-13.39%+16.88% 435M
+4.73%+5.50%+19.45%-8.94% 66.56B
-1.93%+0.54%+58.86%+226.84% 57.64B
+1.07%+42.10%+42.10%+42.10% 42.24B
+3.45%+3.54%-49.20%-56.09% 39.09B
-4.05%+7.01%+62.26%-24.13% 31.91B
-1.99%+33.49%+163.41%-34.35% 31.65B
-0.28%+8.68%+71.42%+87.73% 23.35B
+2.87%+15.37%+10.72%+196.62% 18.92B
-0.13%+2.79%+67.55%+130.16% 17.17B
Average +2.57%+5.42%+43.32%+57.68% 32.9B
Weighted average by Cap. +2.80%+4.31%+44.76%+55.38%

Financials

2026 *2027 *
Net sales 585M 0 195M 171M 157M 146M 277M 18.58B 282M 1.89B 731M 9.12B 733M 717M 31.41B 642M 0 214M 187M 172M 160M 304M 20.4B 309M 2.07B 802M 10.01B 805M 787M 34.48B
Net income 72.01M 0 24.04M 21.01M 19.29M 17.99M 34.1M 2.29B 34.68M 232M 90.01M 1.12B 90.27M 88.31M 3.87B 104M 0 34.6M 30.23M 27.76M 25.89M 49.08M 3.29B 49.91M 334M 130M 1.62B 130M 127M 5.57B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
26-07-03 ILA 2,250.00 -0.31% 15,221
26-07-02 ILA 2,257.00 -0.27% 30,702
26-07-01 ILA 2,263.00 +3.52% 48,355
26-06-30 ILA 2,186.00 +0.51% 117,939
26-06-29 ILA 2,175.00 +2.11% 66,130
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock